JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
Compounding guidance for veterinarians
Learn about the regulatory parameters, quality control assurance, and practice considerations when using compounded products in veterinary medicine.
Cannabis: FAQs for veterinarians
Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…
JAVMA news
More opioids available to veterinarians during ongoing shortage
The Food and Drug Administration announced Dec. 13 that the agency has worked with Pfizer Inc. to help alleviate a shortage of certain injectable…
JAVMA news
A closer look at veterinary homeopathy
Homeopathy is, depending on whom you ask, a gentler and more natural alternative to traditional medicine or an unproven and useless modality, at best.
JAVMA news
EPA imposes new regulations on spot-on flea and tick pesticides, calls for comments
The Environmental Protection Agency announced March 17 it is tightening regulations on dog and cat spot-on pesticides after an increase in adverse…
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
DEA provides update on opioid shortage
The Drug Enforcement Administration released a statement April 10 on the ongoing opioid shortages affecting both human and veterinary medicine.
JAVMA news
AVMA presents Excellence Awards for 2019
During AVMA Convention 2019 this August in Washington, D.C., a number of individuals received AVMA Excellence Awards for contributions in areas such…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
FDA outlines goals, strategy
Improving animal models to consider the influence of disease progression, increasing the efficiency of clinical trials, and increasing access to…
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
Cannabis research for veterinary patients advancing, cautiously
More than half the country has legalized marijuana use in one form or another.
JAVMA news
Tramadol becomes controlled substance
The Drug Enforcement Administration has designated tramadol as a controlled substance
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
JAVMA news
Large animal practitioners grapple with fluid shortage
Large animal practitioners are grappling with a shortage of large-volume bags of polyionic fluids, separate from the ongoing shortage
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Options available to protect against longhorned tick
The invasive longhorned (bush) tick, Haemaphysalis longicornis, has been a growing concern for the veterinary community following the appearance of…
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
JAVMA news
Delegates discuss ethics of vendor incentive programs
The Principles of Veterinary Medical Ethics of the AVMA adequately cover transparency in acceptance of sponsorships, rebates, equipment, and free…